位置:首页 > 蛋白库 > TAPT1_HUMAN
TAPT1_HUMAN
ID   TAPT1_HUMAN             Reviewed;         567 AA.
AC   Q6NXT6; Q8N2S3; Q9NZK9;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 126.
DE   RecName: Full=Transmembrane anterior posterior transformation protein 1 homolog;
DE   AltName: Full=Cytomegalovirus partial fusion receptor;
GN   Name=TAPT1; Synonyms=CMVFR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Embryo;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 21-205, AND POSSIBLE FUNCTION FOR FUSION WITH
RP   HCMV (MICROBIAL INFECTION).
RC   TISSUE=Lung;
RX   PubMed=10640539; DOI=10.1099/0022-1317-81-1-27;
RA   Baldwin B.R., Zhang C.-O., Keay S.;
RT   "Cloning and epitope mapping of a functional partial fusion receptor for
RT   human cytomegalovirus gH.";
RL   J. Gen. Virol. 81:27-35(2000).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   VARIANT OCLSBG VAL-353, CHARACTERIZATION OF VARIANT OCLSBG VAL-353,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=26365339; DOI=10.1016/j.ajhg.2015.08.009;
RA   Symoens S., Barnes A.M., Gistelinck C., Malfait F., Guillemyn B.,
RA   Steyaert W., Syx D., D'hondt S., Biervliet M., De Backer J., Witten E.P.,
RA   Leikin S., Makareeva E., Gillessen-Kaesbach G., Huysseune A., Vleminckx K.,
RA   Willaert A., De Paepe A., Marini J.C., Coucke P.J.;
RT   "Genetic Defects in TAPT1 Disrupt Ciliogenesis and Cause a Complex Lethal
RT   Osteochondrodysplasia.";
RL   Am. J. Hum. Genet. 97:521-534(2015).
CC   -!- FUNCTION: Plays a role in primary cilia formation (PubMed:26365339).
CC       May act as a downstream effector of HOXC8 possibly by transducing or
CC       transmitting extracellular information required for axial skeletal
CC       patterning during development (By similarity). May be involved in
CC       cartilage and bone development (By similarity). May play a role in the
CC       differentiation of cranial neural crest cells (By similarity).
CC       {ECO:0000250|UniProtKB:A2BIE7, ECO:0000250|UniProtKB:Q4VBD2,
CC       ECO:0000269|PubMed:26365339}.
CC   -!- FUNCTION: (Microbial infection) In case of infection, may act as a
CC       fusion receptor for cytomegalovirus (HCMV) strain AD169.
CC       {ECO:0000269|PubMed:10640539}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000269|PubMed:26365339}. Cytoplasm,
CC       cytoskeleton, cilium basal body {ECO:0000269|PubMed:26365339}. Membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6NXT6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6NXT6-2; Sequence=VSP_032842;
CC   -!- DISEASE: Osteochondrodysplasia, complex lethal, Symoens-Barnes-
CC       Gistelinck type (OCLSBG) [MIM:616897]: An autosomal recessive, lethal
CC       syndrome characterized by severe hypomineralization of the entire
CC       skeleton, severe osteopenia, microcephaly, multiple intra-uterine
CC       fractures, and multiple congenital developmental anomalies affecting
CC       the brain, lungs, and kidneys. {ECO:0000269|PubMed:26365339}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the TAPT1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF28308.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK074494; BAC11022.1; -; mRNA.
DR   EMBL; CH471069; EAW92754.1; -; Genomic_DNA.
DR   EMBL; BC066899; AAH66899.1; -; mRNA.
DR   EMBL; AF189251; AAF28308.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS47030.1; -. [Q6NXT6-1]
DR   RefSeq; NP_699196.2; NM_153365.2. [Q6NXT6-1]
DR   AlphaFoldDB; Q6NXT6; -.
DR   BioGRID; 128412; 48.
DR   IntAct; Q6NXT6; 9.
DR   STRING; 9606.ENSP00000385347; -.
DR   iPTMnet; Q6NXT6; -.
DR   PhosphoSitePlus; Q6NXT6; -.
DR   SwissPalm; Q6NXT6; -.
DR   BioMuta; TAPT1; -.
DR   DMDM; 74737002; -.
DR   EPD; Q6NXT6; -.
DR   jPOST; Q6NXT6; -.
DR   MassIVE; Q6NXT6; -.
DR   MaxQB; Q6NXT6; -.
DR   PaxDb; Q6NXT6; -.
DR   PeptideAtlas; Q6NXT6; -.
DR   PRIDE; Q6NXT6; -.
DR   ProteomicsDB; 66775; -. [Q6NXT6-1]
DR   ProteomicsDB; 66776; -. [Q6NXT6-2]
DR   Antibodypedia; 54863; 84 antibodies from 19 providers.
DR   DNASU; 202018; -.
DR   Ensembl; ENST00000405303.7; ENSP00000385347.2; ENSG00000169762.17. [Q6NXT6-1]
DR   GeneID; 202018; -.
DR   KEGG; hsa:202018; -.
DR   MANE-Select; ENST00000405303.7; ENSP00000385347.2; NM_153365.3; NP_699196.2.
DR   UCSC; uc010ied.2; human. [Q6NXT6-1]
DR   CTD; 202018; -.
DR   DisGeNET; 202018; -.
DR   GeneCards; TAPT1; -.
DR   HGNC; HGNC:26887; TAPT1.
DR   HPA; ENSG00000169762; Low tissue specificity.
DR   MalaCards; TAPT1; -.
DR   MIM; 612758; gene.
DR   MIM; 616897; phenotype.
DR   neXtProt; NX_Q6NXT6; -.
DR   OpenTargets; ENSG00000169762; -.
DR   Orphanet; 457378; Complex lethal osteochondrodysplasia.
DR   PharmGKB; PA162405167; -.
DR   VEuPathDB; HostDB:ENSG00000169762; -.
DR   eggNOG; KOG2490; Eukaryota.
DR   GeneTree; ENSGT00390000010628; -.
DR   HOGENOM; CLU_003655_3_0_1; -.
DR   InParanoid; Q6NXT6; -.
DR   OMA; SYFMMHY; -.
DR   OrthoDB; 572763at2759; -.
DR   PhylomeDB; Q6NXT6; -.
DR   TreeFam; TF105962; -.
DR   PathwayCommons; Q6NXT6; -.
DR   SignaLink; Q6NXT6; -.
DR   BioGRID-ORCS; 202018; 85 hits in 1096 CRISPR screens.
DR   ChiTaRS; TAPT1; human.
DR   GenomeRNAi; 202018; -.
DR   Pharos; Q6NXT6; Tbio.
DR   PRO; PR:Q6NXT6; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q6NXT6; protein.
DR   Bgee; ENSG00000169762; Expressed in secondary oocyte and 185 other tissues.
DR   ExpressionAtlas; Q6NXT6; baseline and differential.
DR   Genevisible; Q6NXT6; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; TAS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0016520; F:growth hormone-releasing hormone receptor activity; TAS:UniProtKB.
DR   GO; GO:0051216; P:cartilage development; IEA:UniProtKB-KW.
DR   GO; GO:0030030; P:cell projection organization; IEA:UniProtKB-KW.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0035437; P:maintenance of protein localization in endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0014032; P:neural crest cell development; ISS:UniProtKB.
DR   GO; GO:0001503; P:ossification; IEA:UniProtKB-KW.
DR   GO; GO:1903012; P:positive regulation of bone development; ISS:UniProtKB.
DR   GO; GO:0061036; P:positive regulation of cartilage development; ISS:UniProtKB.
DR   GO; GO:0045724; P:positive regulation of cilium assembly; IDA:UniProtKB.
DR   InterPro; IPR008010; Tatp1.
DR   PANTHER; PTHR13317; PTHR13317; 1.
DR   Pfam; PF05346; DUF747; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell projection; Chondrogenesis;
KW   Ciliopathy; Cilium; Cilium biogenesis/degradation; Cytoplasm; Cytoskeleton;
KW   Developmental protein; Differentiation; Disease variant;
KW   Host-virus interaction; Membrane; Osteogenesis; Phosphoprotein; Receptor;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..567
FT                   /note="Transmembrane anterior posterior transformation
FT                   protein 1 homolog"
FT                   /id="PRO_0000328872"
FT   TRANSMEM        111..131
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        157..179
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        236..256
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        403..423
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        432..452
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          1..60
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          466..499
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        473..499
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         523
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         529
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q4VBD2"
FT   VAR_SEQ         551..567
FT                   /note="KDLLEIDRFTICGNRID -> SVLLCQSGLPEC (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16303743"
FT                   /id="VSP_032842"
FT   VARIANT         353
FT                   /note="D -> V (in OCLSBG; causes mislocalization of the
FT                   protein in the cytoplasm; impairs cilium formation;
FT                   dbSNP:rs869312980)"
FT                   /evidence="ECO:0000269|PubMed:26365339"
FT                   /id="VAR_076497"
FT   VARIANT         465
FT                   /note="E -> K (in dbSNP:rs35606284)"
FT                   /id="VAR_042568"
FT   VARIANT         522
FT                   /note="N -> S (in dbSNP:rs16893137)"
FT                   /id="VAR_042569"
FT   CONFLICT        30
FT                   /note="E -> D (in Ref. 1; BAC11022)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   567 AA;  64260 MW;  2EAB6EF6A7A40E71 CRC64;
     MAGVGDAAAP GEGGGGGVDG PQRDGRGEAE QPGGSGGQGP PPAPQLTETL GFYESDRRRE
     RRRGRTELSL LRFLSAELTR GYFLEHNEAK YTERRERVYT CLRIPRELEK LMVFGIFLCL
     DAFLYVFTLL PLRVFLALFR LLTLPCYGLR DRRLLQPAQV CDILKGVILV ICYFMMHYVD
     YSMMYHLIRG QSVIKLYIIY NMLEVADRLF SSFGQDILDA LYWTATEPKE RKRAHIGVIP
     HFFMAVLYVF LHAILIMVQA TTLNVAFNSH NKSLLTIMMS NNFVEIKGSV FKKFEKNNLF
     QMSNSDIKER FTNYVLLLIV CLRNMEQFSW NPDHLWVLFP DVCMVIASEI AVDIVKHAFI
     TKFNDITADV YSEYRASLAF DLVSSRQKNA YTDYSDSVAR RMGFIPLPLA VLLIRVVTSS
     IKVQGILSYA CVILFYFGLI SLKVLNSIVL LGKSCQYVKE AKMEEKLSNP PATCTPGKPS
     SKSQNKCKPS QGLSTEENLS ASITKQPIHQ KENIIPLLVT SNSDQFLTTP DGDEKDITQD
     NSELKHRSSK KDLLEIDRFT ICGNRID
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024